Propranolol assay
AssigneeHoffmann-La Roche Inc.
InventorSidney Spector
Life of this patent
Estimating the term…
Abstract
New hapten compositions useful in preparing antigens which may be employed in eliciting antibodies useful in immunoassay, particularly radioimmunoassay for propranolol. Utilizing an enantiomer in formation of the hapten allows preparation of an antibody which is able to discriminate between enantiomers selectively.
Claims6
An antibody specific to propranolol and the enantiomers thereof, said antibody being prepared by innoculating a host animal with an antigen consisting essentially of a propranolol hapten of the formula ##STR14## wherein n is an integer from 2 to 6;
- said hapten being covalently bonded to an immunogenic carrier material through the carboxyl group.
A method for the assay of propranolol or enantiomers thereof in a sample which method comprises mixing said sample with a known amount of a labelled propranolol derivative and an antibody which will selectively complex with said propranolol or its enantiomers thereof, and with said labelled propranolol derivative, measuring the degree of binding of said labeled propranolol derivative with said antibody, and determining the amount of propranolol or enantiomers thereof present in such sample by comparing said degree of binding to a standard curve obtained by mixing known amounts of propranolol or enantiomers thereof with fixed amounts of said labeled propranolol derivative.
Dependencies are inferred from the claim text.